Sitoiganap

· Epitopoietic Research Corporation-Belgium (E.R.C.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sitoiganap, covering 2022-06-17 to 2022-06-17. Get the full timeline:

Most recent: EMA Application withdrawn: Sitoiganap (allogeneic glioma tumor cell lysates (inactivated);allogeneic glioma tumor cells (inactivated);autologous glioma tumor cell lysates (inactivated);autologous glioma tumor cells (inactivated)) — Epitopoietic Research Corporation-Belgium (E.R.C.)

See pricing